Compounds > oxazoles
Page last updated: 2024-08-21

oxazoles and prostaglandin d2

oxazoles has been researched along with prostaglandin d2 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuang, DM; Majewska, MD1
Jungermann, K; Nath, A; Pestel, S; Schieferdecker, HL1
Baugh, MD; Edwards, DR; Gavrilovic, J; Hogan, A; Hughes, DA; Sampson, MJ; Worley, JR1
Chen, J; Chen, Q; Jiang, H; Shen, J; Shen, X; Sun, T1
Huang, XH; Sun, K; Wang, Q1
Cancedda, FD; Cancedda, R; Ulivi, V1
Chen, XL; Cheng, T; Chu, TG; Gao, WY; Jiang, LF; Li, XY; Li, ZJ; Pan, H; Yang, JQ; Yi, CG; Yu, Q; Zhang, GY; Zheng, MH; Zhou, FY1
Blomeyer, C; Kehl, F; Lange, M; Lazariotto, M; Lotz, C; Pociej, J; Redel, A; Roewer, N; Schmidt, J; Smul, TM; Stumpner, J; Tischer-Zeitz, T1

Other Studies

8 other study(ies) available for oxazoles and prostaglandin d2

ArticleYear
Benzodiazepines enhance the muscimol-dependent activation of phospholipase A2 in glioma C6 cells.
    The Journal of pharmacology and experimental therapeutics, 1985, Volume: 232, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Arachidonic Acid; Arachidonic Acids; Cell Line; Chromatography, High Pressure Liquid; Diazepam; Drug Interactions; Enzyme Activation; Glioma; Muscimol; Neuroglia; Oxazoles; Phospholipases; Phospholipases A; Phospholipases A2; Prostaglandin D2; Prostaglandins D; Rats; Receptors, GABA-A

1985
Inhibition of prostaglandin D2 clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelate.
    Biochemical pharmacology, 2003, Aug-15, Volume: 66, Issue:4

    Topics: Animals; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Complement C5a; Enzyme Inhibitors; Hepatocytes; Liver; Male; Metabolic Clearance Rate; Oxazoles; Perfusion; Phenylacetates; Prostaglandin D2; Rats; Rats, Wistar; Receptors, Thromboxane; Sulfonamides; Thromboxane B2; Thromboxane-A Synthase

2003
Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid.
    The Journal of biological chemistry, 2003, Dec-19, Volume: 278, Issue:51

    Topics: ADAM Proteins; ADAMTS4 Protein; Alitretinoin; Cell Line; Humans; Macrophages; Matrix Metalloproteinase 9; Metalloendopeptidases; Metalloproteases; Oxazoles; Procollagen N-Endopeptidase; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription Factors; Transcription, Genetic; Tretinoin; Tyrosine

2003
A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist.
    Analytical biochemistry, 2004, Dec-15, Volume: 335, Issue:2

    Topics: alpha-Galactosidase; Anilides; Cells, Cultured; Chromans; CREB-Binding Protein; Drug Evaluation, Preclinical; Genes, Reporter; Indomethacin; Ligands; Nuclear Proteins; Oxazoles; Pioglitazone; PPAR gamma; Prostaglandin D2; Protein Binding; Rosiglitazone; Thiazolidinediones; Trans-Activators; Troglitazone; Two-Hybrid System Techniques; Tyrosine; Yeasts

2004
PPAR gamma inhibits growth of rat hepatic stellate cells and TGF beta-induced connective tissue growth factor expression.
    Acta pharmacologica Sinica, 2006, Volume: 27, Issue:6

    Topics: Anilides; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Gene Expression; Hepatocytes; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Ligands; Oxazoles; PPAR gamma; Prostaglandin D2; Rats; RNA, Messenger; Transforming Growth Factor beta1; Tyrosine

2006
15-deoxy-delta 12,14-prostaglandin J(2) inhibits the synthesis of the acute phase protein SIP24 in cartilage: Involvement of COX-2 in resolution of inflammation.
    Journal of cellular physiology, 2008, Volume: 217, Issue:2

    Topics: Acute-Phase Proteins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Cartilage; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Diclofenac; Dinoprostone; Down-Regulation; Enzyme Induction; Enzyme Repression; Imidazoles; Inflammation; Intramolecular Oxidoreductases; Lipocalin-2; Lipocalins; Lipopolysaccharides; Mice; NF-kappa B; Oncogene Proteins; Oxazoles; p38 Mitogen-Activated Protein Kinases; Phenylurea Compounds; PPAR alpha; PPAR gamma; Prostaglandin D2; Prostaglandin-E Synthases; Protein Kinase Inhibitors; Pyridines; Signal Transduction; Time Factors; Tyrosine

2008
Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro.
    Archives of dermatological research, 2009, Volume: 301, Issue:7

    Topics: Cell Growth Processes; Cells, Cultured; Cicatrix, Hypertrophic; Connective Tissue; Connective Tissue Growth Factor; Dose-Response Relationship, Immunologic; Extracellular Matrix; Fibroblasts; Humans; Oxazoles; PPAR gamma; Prostaglandin D2; Transcriptional Activation; Transforming Growth Factor beta; Tyrosine

2009
Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo.
    Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:1

    Topics: Anilides; Animals; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxazoles; PPAR alpha; PPAR gamma; Prostaglandin D2; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tyrosine

2011